Monday, 8 October 2018

Neuropathology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2023

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Neuropathology Market Research Report- Global Forecast till 2023” Gives industry size, top players and worldwide demand
                                                                                                                          
Market Synopsis of the Global Neuropathology Market
Neuropathology pertains to the aliment of nerves reculting in pain and numbness of the limbs and it is gaining prominence in this market. The increasing incidence of musculoskeletal conditions and technological advancements in medical diagnostic devices are some factors responsible for the growth of the global neuropathology market.
The number of patients suffering from cerebrovascular disorders has increased rapidly and has reached an all-time high in the past few years. There has been a significant rise in the number of surgeries associated with the treatment of such disorders. As the neurosurgeries and spinal surgeries are very critical, continuous monitoring during the whole procedure proves to be beneficial as the information about the electrical signals in brain and the nerves can be obtained in real time.
Biopsies primarily consist of the skin. The recently developed neuropathy test, the epidermal nerve fiber density testing (ENFD) in which the nerve fibers of the skin is analysed by performing a  punch skin biopsy to identify small fiber neuropathies. This pathology test is becoming available in selected labs as well as a few universities; it replaces the traditional sural nerve biopsy test and is less invasive. It is used to identify painful small fiber neuropathies.
According to the Labor Force Survey (LFS), about 553,000 cases were registered for all work-related musculoskeletal disorder out of the total of 1,243,000 cases. Many healthcare professionals have started using these diagnostics techniques, especially in tertiary care centers and specialty hospitals which may promote and increase the demand for Neuropathology.
The Global market of Neuropathology is expected to grow at a CAGR of approximately 6% during the forecast period 2017-2023.
Key Players
Many new companies have jumped into the market in order to make the most out of the opportunities. Companies are implementing the strategies of mergers and acquisitions with other players.
·         ARUP Laboratories
·         Therapath LLC
·         Abbott Laboratories
·         Laboratory Corporation of America Holdings
·         Thermo Fisher Scientific Inc.
·         F. Hoffmann-La Roche Ltd.
·         Sakura Finetek USA Inc.
·         Danaher Corporation
·         Quest Diagnostics Incorporated
·         Agilent Technologies Inc.N
·         NeoGenomics Laboratories
Segmentation
The Neuropathology is segmented on the basis of diagnosis test, application, and end-users.
On the basis of diagnostic test, the market is segmented into the biopsy, body fluids, peripheral blood smears, tissue resections, and others 
The biopsy sub-segment is divided into Epidermal nerve fiber density testing (ENFD), Sural nerve biopsy test, bone-marrow biopsies, lymph-node biopsies and others
On the basis of product, the application market is segmented into cerebral hypoxia and stroke, perinatal disorders, CNS infections, demyelinative diseases, brain tumors, neurodegenerative diseases, inherited metabolic disorders, peripheral neuropathy, and myopathology
On the basis of end-user, the market is segmented into hospitals, clinics, research centers and others.
Regional Analysis
The Global Neuropathology Market consists of countries namely America, Europe, Asia Pacific, and the Middle East.
North America dominated the global neuropathology market owing to the increasing healthcare expenditure in North America since 2016. U.S. has some of the best hospitals in the world with state of the art infrastructure. Most of the hospitals and their neurology departments are well equipped with the equipment that is required for the working of the neuropathology techniques. Various organizations and private companies are engaged in the activities of spreading awareness about the benefits of the neuropathology test among common people through various educational and marketing ways. As a result, huge numbers of people are opting for the neuropathology tests as a point of care. The country has been developing number of academic courses to develop skilled personnel in the neuropathology field over the years. Hence the availability of the neuropathology specialists in North American countries is high.
Europe is the second largest market for neuropathology market. For Europe, the neuropathology market including the brain tumors market is regarded as a strong competitive market. European countries are now making efforts in promoting the benefits of the intraoperative neurophysiological monitoring services. Patient friendly healthcare and insurance policies are making a positive impact on the people taking medical assistance.
Asia Pacific is the fastest growing region over the forecast period. The healthcare spending in Asia increased due to an extension of state health care programs and the increasing affluence of the population. India, in specific, saw an expansion in spending due to a government resolution to enhance healthcare services.

Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry

       
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Cowden Syndrome Market 2018 - Industry Growth, Analysis, Size and Share to 2023

Cowden syndrome (CS), a clinical disorder and inherited condition that is characterized primarily by multiple, noncancerous growths called hamartomas on various parts of the body.  The occurrence of CS can lead to the risk of developing certain types of cancer including Breast, thyroid, and endometrial cancers.
Although a rare kind of disease, over the past couple of years, the prevalence of Cowden syndrome seems to be increasing.  Besides, it being a risk factor for cancerous tumors, the Cowden syndrome is taken seriously, and huge investments are transpired in the development of treatment. With the interventions of advanced technologies, today, specialists are developing breakthrough therapies & treatments that are phenomenally close. Therefore, the market for Cowden syndrome is growing globally.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5096
Acknowledging the traction, the market is vibrating with currently, Market Research Future (MRFR) in its recently published study report asserts that the global Cowden syndrome market gaining further prominence will demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking 6.7% CAGR during 2017 – 2023.
Evidently, technological advancements transpired into the field of medical science are providing impetus to the growth of the Cowden syndrome market further escalating it pervasively. However, efforts of key market players that are constantly bringing improvements in the treatments are rather seminal. Hence the market players are the main force driving the market growth exclusively.
The Cowden syndrome market still consists of a limited number of treatments; however, governments of various countries have taken up many initiatives to spread the awareness and to support the manufacturers for research and development of drugs, medical devices, and technology. These initiatives are paying off well by increasing the market size substantially, raising the awareness among people about the disease and the availability of its treatments.
On the other hand, the side effects and the high cost of the medicines associated with the treatment are some of the key factors impeding the market growth. Also, the limited vision, knowledge, and awareness towards the treatment’s availability are obstructing the market growth of Cowden syndrome, especially in the underdeveloped regions such as the Middle Eastern and African region.

Global Cowden Syndrome Market – Segments
The MRFR analysis is segmented into four key dynamics;
By Sites                     : Breast, Thyroid, Endometrium (uterus), Colorectal, Kidney, and Skin (melanoma), among others.
By Treatments         : Genetic Testing, Chemotherapy (Anthracyclines, Taxanes, Antimetabolites, Alkylating Agents and others.), Targeted Therapy (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, and others.), Surgery & Radiation Therapy, Hormone Therapy (Selective Estrogen-Receptor Modulators (SERMs), Aromatase Inhibitors, and others.).
By End-Users           : Hospital & Clinics, ambulatory care centers, and others.
By Regions                :  North America, Europe, APAC and the Rest-of-the-World.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/5096
Global Cowden Syndrome Market – Regional Analysis
The North American region dominates the global Cowden syndrome market, accounting for a significant market share. The region is expected to continue with its dominance throughout the forecast period. The increasing prevalence of Cowden syndrome and cancer is predominantly driving the market growth in the region.
Additional factors acting as a tailwind to the market growth include high healthcare expenditure, huge technological development, and strong government support for research & development.  Simultaneously, the presence of the leading players and increasing availability of funds are impacting the market growth in this region, positively.
The European region accounts for the second-largest market for Cowden syndrome treatment, emerging as another lucrative market, globally. Germany, backed by its sizeable medical device industry and its vast Cowden syndrome treatment market is expected to drive the market growth in the region. Favorable governmental support and initiatives drive the growth in the market extensively. The proliferating healthcare sector in the region, backed by the resurging economy is fostering the market growth radiantly.
The Asia Pacific region is emerging as a promising market for Cowden syndrome treatments owing to the increasing cases of cancer. The region is expected to escalate rapidly over the forecast period. Factors such as the huge development opportunities along with the constantly developing healthcare infrastructure in the Asia Pacific region is propelling the market growth. Countries such as India and China, backed by the rapidly increasing the economy and increasing government support are expected to lead the market in this region.

Global Cowden Syndrome Market – Competitive Analysis
Cowden syndrome market is highly competitive. The key strategies traced from the analysis of recent developments of the key players include product launch, agreement & partnership, acquisition, and expansion. Key manufacturers utilizing breakthrough manufacturing technology strive to develop a comprehensive range of safe and reliable solutions portfolio.
Key Players:
The global cowden syndrome market is driven by some of the leading players including GlaxoSmithKline Plc. (UK), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (US), Amgen, Inc. (US), AstraZeneca Plc. (UK), Sanofi (France), Bristol-Myers Squibb Company (US), AbbVie Inc. (US), Takeda Pharmaceuticals (Japan), Spectrum Pharmaceuticals Inc. (US), Pfizer, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (US), Janssen Biotech, Inc. (US), Oncomed Pharmaceuticals (US), and Immunomedics (US).
Industry/Innovation/ Related News:
September 21, 2018 - GlaxoSmithKline Plc. (UK), a leading global research-based pharmaceutical and healthcare company partnering with the Tres Cantos Open Lab Foundation (TCOLF), a company addressing the translational and funding gap existing in Global Health (GH) announce additional £5m funding for open innovation research in diseases including rear diseases such as Cowden syndrome impacting the developing world.
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/5096   
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Vocal Cord Paralysis Market Growth Opportunities, Analysis and Forecasts Report 2018-2023

Market Synopsis
The global vocal cord paralysis market is presumed to expand at 6.4 % CAGR during the forecast period (2017-2023) owing to the increasing technological advancements, asserts Market Research Future (MRFR). Vocal cord paralysis is a condition where the vocal cords are unable to move either on one side or both the sides and are mainly caused due to surgical trauma, neurological diseases, malignancies, delayed endotracheal intubation, choking, and strokes. Diabetes mellitus also results in neuropathy which leads to vocal cord paralysis.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5079
Drivers and Constraints Impacting the Market
With the growing advancements in technology, growing assistance from the government, rising reimbursement and funding, growing awareness among the people regarding vocal cord paralysis, and improvement in regulatory framework, the global market for vocal cord paralysis is likely to propel during the assessment period. Several latest endoscopic technologies such as endoscopic mucosal resection (EMR), endoscopic ultrasound (EUS), CT colonography, narrow band imaging, microendoscopy, mucosal ablation therapies, and capsule endoscopy have improved the treatment process to a great extent.
On the flip side, poor healthcare system prevalent in low and middle-income countries, and challenges faced in research and development activities are estimated to retard the market growth in the coming years. Moreover, lack of skilled physicians is also expected to hinder the market growth.
Global Vocal Cord Paralysis Market: Segmental Analysis
The global vocal cord paralysis has been segmented on the basis of type, treatment, diagnosis, end-user, and region.
By mode of type, the global vocal cord paralysis market has been segmented into bilateral and unilateral.
By mode of diagnosis, the global vocal cord paralysis market has been segmented into endoscopy, stem cell therapy, gene therapy, laryngeal electromyography (LEMG), corticosteroids, nerve stimulation, and others such as CT scans, X-rays, and MRI scans.
By mode of treatment, the global vocal cord paralysis market has been segmented into surgery, voice therapy, and others. The segment for surgery is further sub-segmented into tracheotomy, phono surgery, bulk injection, adenoidectomy, cordectomy, and nerve-muscle implant.
By mode of end-users, the global vocal cord paralysis market has been segmented into clinics, hospitals, diagnostic centers, and others.
Regional Insights
Geographically, the vocal cord paralysis market span across regions namely, America, Europe, Asia Pacific, and the Middle East and Africa.
Among all the regions, the American region is estimated to dominate the global market due to increasing awareness among the people regarding vocal cord paralysis and high expenditure on healthcare. For instance, according to the Centers for Disease Control and Prevention, the total healthcare expenditure in the U.S. in 2015 was reported to touch USD 3.2 trillion.
Europe is estimated to hold the second position in the market owing to the improvement in the reimbursement policies in the healthcare sector along with the support provided by the government for research and development activities in this region.
The Asia Pacific region is considered to be the fastest growing market across the globe owing to the developing healthcare technology along with the presence of huge patient population. As per the Australian Institute of Health and Welfare, in 2015 and 2016, the total expenditure on healthcare was estimated to touch USD 170.4 billion.
On the other hand, the Middle East and African region are anticipated to register the least market share owing to poor medical facilities and lack of technical knowledge.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/5079
Industry News
A team of researchers at the University of Wisconsin-Madison announced that they had developed vocal cords in the laboratory and these petri dish voice boxes have proven to make dead dogs bark. People with damaged vocals cords can regain their voices with these lab-grown vocal cords.
Competitive Dashboard
The major players operating the global market are Abbott (U.S.), Medtronic Plc (Ireland), Olympus Corporation (Japan), KARL STORZ GmbH & Co. (Germany), Hoya Corporation (Japan), Sonova Holdings AG (Switzerland), Cochlear Limited (Australia), William Demant Holdings A/S (Denmark), Smith & Nephew Plc (U.K), Stryker Corporation (U.S.), Acclarent Inc. (U.S.), and others.
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/5079
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Cell Therapy Market: Global Analysis, Industry Growth, Current Trends and Forecast till 2023

The global cell therapy market is due to grow at a CAGR of 10.6% during the forecast period of 2017 to 2023 according to Market Research Future's latest report on the subject. Cell therapy has emerged as a transformative field in biotechnology due to its use for the targeting of various diseases at a cellular level. The above-average growth expected by this market will primarily be due to the rapidly advancing healthcare sector and growing breakthrough research and development activities.
Cell therapy is finding a growing number of applications in healthcare and is often used in combination with gene therapy. Presently, applications of cell therapy include urinary problems, cancers, autoimmune disease, and infectious disease among several others. The growing prevalence of chronic and lifestyle diseases is an important driver for the cell therapy market. Cell therapy is also being developed in regenerative medicine which carries massive potential once it clears the research phase. Increasing geriatric population with health issues and technological advancements are some other factors governing market growth. government assistance for research and improvements being made in existing regulatory frameworks are expected to pave the way for future market opportunities.
However, it should be noted that the high cost of manufacturing at present and the lack of awareness or appropriate healthcare infrastructure are expected to challenge market growth.
The Cell therapy market is expected to grow at a CAGR 10.6% during the forecast period of 2017-2023.
A number of factors such as increasing geriatric population, increasing government assistance, replacement of animal testing model, technological advancements, and improvement in the regulatory framework, are propelling the growth of cell therapy market. Rising prevalence of chronic disorders is also fuelling up the market to a great extent.
Despite these drivers, there are some issues associated with cell therapy market. Challenges in research and development, the high cost of manufacturing, and poor healthcare system in low and middle-income countries may hamper the growth of the market.
Cell Therapy Market Major Key Players
·         Novartis AG
·         GlaxoSmithKline plc
·         MEDIPOST
·         Osiris
·         PHARMICELL
·         NuVasive, Inc.
·         JCR Pharmaceuticals Co., Ltd
·         ANTEROGEN.CO.,LTD.
·         Cynata
·         CELLECTIS
·         BioNTech IMFS
·         EUFETS GmbH
·         Cognate
·         PluristemGrupo Praxis
·         Genzyme Corporation
·         Advanced Tissue and others. 
Cell Therapy Market Segmentation
The cell therapy market is segmented on the basis of type, technology, cell source, application, and end-user.
On the basis of type, the market is segmented into autologous, and allogeneic.
On the basis of technology, the market is classified into somatic cell technology, cell immortalization technology, viral vector technology, genome editing technology, cell plasticity technology, and three-dimensional technology. Viral vector technology is further segmented into Ex vivo gene modification of cells and In vivo gene modification of cells.
On the basis of cell source, the market is classified into induced pluripotent stem cells (iPSCs), bone marrow, umbilical cord blood-derived cells, adipose tissue, and neural stem cell.
On the basis of application, the market is classified into musculoskeletal, cardiovascular, gastrointestinal, neurological, oncology, dermatology, wounds and injuries, ocular, and others.
On the basis of end-users, the market is segmented into hospital & clinics, regenerative medicine centers, diagnostic centers, research institutes, and others.
Cell Therapy Market Regional Analysis
The Americas dominate the cell therapy market owing to the rise in awareness among people, and high healthcare expenditure.
Europe holds the second position in cell therapy market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region. On August 30, 2017. Novartis AG, A Switzerland based market leader, received FDA approval for Kymriah suspension for intravenous infusion. It is the first chimeric antigen receptor T cell therapy (CAR-T).
The Asia Pacific is the fastest growing cell therapy market owing to the huge patient pool and developing healthcare technology.

Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
LIST OF TABLES
Table 1 Cell Therapy Industry Synopsis, 2017 – 2023
Table 2 Cell Therapy Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Cell Therapy Market By Region, 2017 – 2023, (USD Million)
Table 4 Cell Therapy Market By Type, 2017 – 2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Cell Therapy Market
Figure 3 Segmentation Market Dynamics For Cell Therapy Market
Figure 4 Global Cell Therapy Market Share, By Type 2016
...Continued


         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Hirsutism Treatment Market Size, Emerging Technologies, Future Trends, Competitive Analysis and Segments Poised for Strong Growth in Future 2023

Market Synopsis
The global hirsutism market is presumed to expand at 13.6 % CAGR during the forecast period (2017-2023) owing to the rising expenditure on personal care, asserts Market Research Future (MRFR). Hirsutism is a condition where a woman faces unwanted and excessive male-pattern hair growth on her body. The unwanted hair growth is mainly found in areas such as back, face, stomach, and chest and is majorly caused due to hyperandrogenism which may be ovarian or adrenal. Some of the common symptoms include balding, deepening of voice, decreased breast size, acne, enlargement of the clitoris, and others.
Drivers and Constraints Impacting the Market
Women are nowadays getting more conscious regarding their looks which is further influencing them to opt for hirsutism treatment. Laser therapy is one the most demanding treatments among the women driving the market. With the increasing availability of treatment and products along with the increasing awareness regarding hirsutism is propelling the market growth during the assessment period. Also, growing demand from emerging economies such as South America and Asia are likely to foster the market. Moreover, hospitals are investing in technology upgradation in order to provide effective treatment to their patients which is further expanding the market growth during the review period.
On the flip side, low per capita healthcare expenditure among the low and middle-income countries and lack of awareness regarding hirsutism are some of the major factors likely to retard the market growth in the coming years. Moreover, the cost of medical laser systems is high which makes it hard to afford for every individual, thereby hampering the market growth.
Global Hirsutism Market: Segmental Analysis
The global hirsutism market has been segmented on the basis of type, diagnosis, treatment, end-user, and region.
By mode of type, the global hirsutism market has been segmented into secondary hirsutism, idiopathic hirsutism, and others.
By mode of diagnosis, the global hirsutism market has been segmented into physical examination, blood tests, imaging tests, and others. Among these, the segment for blood-test is further sub-segmented into DHEA-sulfate test, testosterone level test, and others. The physical examination segment is sub-segmented into palpation and percussion, inspection, auscultation, and others. The imaging test is sub-segmented into CT scan, ultrasound, and others.
By mode of treatment, the global hirsutism market has been segmented into procedures, medications, and others. Among these, the medications segment is sub-segmented into anti-androgens, topical cream, oral contraceptives, and others. Procedures comprise laser therapy, electrolysis, and others.
By mode of end-users, the global hirsutism market has been segmented into hospitals and clinics, academic institutes, medical research centers, and others.

Regional Insights
Geographically, the hirsutism market span across four main regions namely, Europe, America, Asia Pacific, and the Middle East and Africa.
Among all the regions, America is estimated to hold the largest market share owing to the increasing demand for treatment and technological advancements in this region. North America is considered to be the dominant region in America. The U.S. generates the highest revenue in this region.
Asia Pacific is considered to be the fastest growing region owing to increasing expenditure on healthcare, growing awareness regarding hirsutism, and availability of affordable healthcare facilities in this region.
Europe is considered to be the second largest market owing to the presence of countries such as France, Germany, and the U.K. On the other hand, the Middle East and Africa showcases the least market share and is anticipated to expand at a slower rate than the average growth rate.
Industry News
A change in the law in Western Australia has drastically reduced the price of laser hair removal. SILK Laser Clinics, which once sold a 67 % stake to the Advent Partners in a deal valuing it between $50 million and $100 million, has opened its first two clinics in WA.
Competitive Dashboard
The major players operating the global market are Bayer AG (Germany), Bristol-Myers Squibb Company (US), AbbVie Inc. (US), Allergan (Republic of Ireland), Sun Pharmaceutical Industries Ltd. (India), Jubilant Cadista (US), Pfizer Inc. (US), and others.
         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com